Korean J Otolaryngol-Head Neck Surg.  2005 Oct;48(10):1205-1210.

Prognostic Value of Electroneurography in Bell's Palsy and Ramsay-Hunt's Syndrome

Affiliations
  • 1Department of Otolaryngology-HNS, The Catholic University of Korea College of Medicine, Seoul, Korea. leedh0814@catholic.ac.kr

Abstract

BACKGROUND AND OBJECTIVES
This study evaluated the usefullness of electroneurography (ENoG) as a prognostic indicator in Bell's palsy and Ramsay-Hunt's syndrome. SUBJECTS AND METHOD: Retrospective case-series review in a university-based hospital. The treatment consisted uniformly of high-dose prednisolone, dextran, vasodilators, carbogen therapy, and stellate ganglion block. Acyclovir was administered in the case of Ramsay-Hunt's syndrome. ENoG was performed 7 to 10 days in Bell's palsy and 10 to 14 days in Ramsay-Hunt's syndrome. The recovery of the facial nerve function was documented using the House-Brackmann grading system. All patients were followed up until they recovered or at least for 3 months. RESULTS: The recovery rates to House-Brackmann grade II or better were 96.3% in Bell's palsy and 84.6% in herpes zoster oticus. There was no significant difference of ENoG value between recovery and non-recovery groups in Bell's pasly and in herpes zoster oticus. The logistic regression model between ENoG values and the chance of recovery was not found in Bell's palsy and in herpes zoster oticus. CONCLUSION: Although ENoG accurately predicts the percentage of remaining motor axons of the facial nerve, it cannot give a precise information on the prognosis or recovery rate of facial paralysis.

Keyword

Bell palsy; Herpes zoster oticus; Prognosis; Electrodiagnosis

MeSH Terms

Acyclovir
Axons
Bell Palsy*
Dextrans
Electrodiagnosis
Facial Nerve
Facial Paralysis
Herpes Zoster Oticus
Humans
Logistic Models
Prednisolone
Prognosis
Retrospective Studies
Stellate Ganglion
Vasodilator Agents
Acyclovir
Dextrans
Prednisolone
Vasodilator Agents
Full Text Links
  • KJORL-HN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr